AI
Tuesday, March 27, 2012 11:06:18 AM
AMRN: going to be a very nice play.
FDA approval date - July 26th
Phase III data were very positive
Patent for Amrn 101 is approved
Multiple analysts with price target above $20
Buyout rumors
Or we should see partnerships soon
Been buying the 11.40-11.50 the pass few days.
FDA approval date - July 26th
Phase III data were very positive
Patent for Amrn 101 is approved
Multiple analysts with price target above $20
Buyout rumors
Or we should see partnerships soon
Been buying the 11.40-11.50 the pass few days.
These are my opinions.. Please do your DD before buying!
